TW306921B - - Google Patents

Download PDF

Info

Publication number
TW306921B
TW306921B TW081109648A TW81109648A TW306921B TW 306921 B TW306921 B TW 306921B TW 081109648 A TW081109648 A TW 081109648A TW 81109648 A TW81109648 A TW 81109648A TW 306921 B TW306921 B TW 306921B
Authority
TW
Taiwan
Prior art keywords
compound
item
patent application
formula
alkyl
Prior art date
Application number
TW081109648A
Other languages
English (en)
Chinese (zh)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of TW306921B publication Critical patent/TW306921B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
TW081109648A 1991-12-05 1992-12-02 TW306921B (Sortimente)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125900A GB9125900D0 (en) 1991-12-05 1991-12-05 Piperazine derivatives

Publications (1)

Publication Number Publication Date
TW306921B true TW306921B (Sortimente) 1997-06-01

Family

ID=10705770

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109648A TW306921B (Sortimente) 1991-12-05 1992-12-02

Country Status (22)

Country Link
US (1) US5710149A (Sortimente)
EP (1) EP0625977B1 (Sortimente)
JP (1) JP3262333B2 (Sortimente)
KR (1) KR100244626B1 (Sortimente)
AT (1) ATE162527T1 (Sortimente)
AU (1) AU658242B2 (Sortimente)
BR (1) BR9206861A (Sortimente)
CA (1) CA2124680C (Sortimente)
DE (1) DE69224212T2 (Sortimente)
DK (1) DK0625977T3 (Sortimente)
ES (1) ES2111654T3 (Sortimente)
FI (1) FI942635L (Sortimente)
GB (2) GB9125900D0 (Sortimente)
GR (1) GR3025988T3 (Sortimente)
HU (2) HUT70755A (Sortimente)
IL (1) IL103944A (Sortimente)
MX (1) MX9206939A (Sortimente)
NZ (1) NZ246007A (Sortimente)
RU (1) RU2125566C1 (Sortimente)
TW (1) TW306921B (Sortimente)
WO (1) WO1993011122A1 (Sortimente)
ZA (1) ZA929317B (Sortimente)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8322764B2 (en) 2010-06-11 2012-12-04 Mag-Lok Tools, Inc. Modular long handled tool component system

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US5439915A (en) * 1994-10-20 1995-08-08 American Home Products Corporation Pyrido[3,4-B]indole carboxamide derivatives as serotonergic agents
US5466688A (en) * 1994-10-20 1995-11-14 American Home Products Corporation Pyrido[3,4-B]indole derivatives as serotonergic agents
US5451584A (en) * 1994-11-10 1995-09-19 American Home Products Corporation N-alkynyl carboxamides as sertonergic agents
US5541179A (en) * 1995-05-02 1996-07-30 American Home Products Corporation Tropon-2-one piperazine carboxamides as serotonergic agents
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US5610164A (en) * 1996-07-24 1997-03-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
US6482827B1 (en) * 1997-07-10 2002-11-19 Pharmacia & Upjohn S.P.A. Matrix metalloproteinase inhibitors
CN1312802A (zh) * 1998-06-15 2001-09-12 美国家用产品公司 作为5－羟色胺能药物的环烷基取代的芳基哌嗪、哌啶和四氢吡啶
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
KR20040091119A (ko) * 2002-03-12 2004-10-27 와이어쓰 키랄 1,4-이치환된 피페라진의 제조방법
CA2477892C (en) * 2002-03-12 2010-11-23 Gregg Brian Feigelson Process for synthesizing chiral n-aryl piperazines
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine
ES2291722T3 (es) * 2002-12-03 2008-03-01 Hoffmann La Roche Aminoalcoxiindoles como ligandos 5-ht6-receptores para el tratamiento de transtornos del snc.
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
MX2007010524A (es) * 2005-03-01 2008-01-16 Wyeth Corp Formas cristalinas y amorfas del clorhidrato 4-ciano-n-{(2r)-2-[4- (2,3-dihidro-benzo[1-4]dioxin-5-il)-piperazin-1-il]-propil}-n- piridin-2-il-benzamida.
US7731940B2 (en) 2006-01-25 2010-06-08 The Regents Of The University Of California Compositions and methods related to serotonin 5-HT1A receptors
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
PL2155736T3 (pl) * 2007-05-14 2012-09-28 Sk Biopharmaceuticals Co Ltd Nowy związek, karbamoiloksyaryloalkanoiloarylopiperazyna, kompozycje farmaceutyczne zawierające ten związek oraz sposoby leczenia bólu, stanu lękowego i depresji przez podawanie tego związku
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU534071A1 (ru) * 1974-03-26 1980-04-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср -Замещенные пиперазины,обладающие психотропной активностью
AU577802B2 (en) * 1983-10-17 1988-10-06 Duphar International Research B.V. Blood-pressure lowering piperazine derivatives
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IE950248L (en) * 1989-04-22 1990-10-22 Wyeth John & Brother Ltd Piperazine derivatives
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
US5382583A (en) * 1989-04-22 1995-01-17 John Wyeth & Brother, Limited Piperazine derivatives
ES2140374T3 (es) * 1989-04-22 2000-03-01 American Home Prod Derivados de piperazina funcionalizados con alquilos terciarios.
US4935511A (en) * 1989-09-26 1990-06-19 Rorer Pharmaceutical Corporation Benzoxazine and benzoxazepine carboxamide 5-HT3 antagonists
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
GB9022790D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
GB9112697D0 (en) * 1991-06-13 1991-07-31 Shell Int Research Biocidal compounds
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9308725D0 (en) * 1993-04-27 1993-06-09 Wyeth John & Brother Ltd Piperazine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8322764B2 (en) 2010-06-11 2012-12-04 Mag-Lok Tools, Inc. Modular long handled tool component system

Also Published As

Publication number Publication date
EP0625977A1 (en) 1994-11-30
BR9206861A (pt) 1995-11-21
GB2262093B (en) 1995-06-07
MX9206939A (es) 1993-06-01
CA2124680C (en) 2004-02-17
ES2111654T3 (es) 1998-03-16
GB9225121D0 (en) 1993-01-20
ATE162527T1 (de) 1998-02-15
HU9401686D0 (en) 1994-09-28
CA2124680A1 (en) 1993-06-10
DE69224212T2 (de) 1998-04-30
NZ246007A (en) 1995-04-27
GB2262093A (en) 1993-06-09
RU2125566C1 (ru) 1999-01-27
ZA929317B (en) 1994-06-01
US5710149A (en) 1998-01-20
AU2953792A (en) 1993-06-28
FI942635A7 (fi) 1994-06-03
GB9125900D0 (en) 1992-02-05
FI942635A0 (fi) 1994-06-03
KR100244626B1 (ko) 2000-05-01
HU211518A9 (en) 1995-11-28
DE69224212D1 (de) 1998-02-26
GR3025988T3 (en) 1998-04-30
WO1993011122A1 (en) 1993-06-10
IL103944A0 (en) 1993-05-13
JPH07501803A (ja) 1995-02-23
DK0625977T3 (da) 1998-05-04
JP3262333B2 (ja) 2002-03-04
IL103944A (en) 1997-06-10
AU658242B2 (en) 1995-04-06
RU94030476A (ru) 1996-04-20
EP0625977B1 (en) 1998-01-21
FI942635L (fi) 1994-06-03
HUT70755A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
TW306921B (Sortimente)
JP3274865B2 (ja) ５−ｈｔレセプター拮抗物質としてのピペラジン誘導体
EP1261601B1 (de) Substituierte indole zur modulierung von nfkb-aktivität
JP3087763B2 (ja) 新規な複素環式化合物およびそれを含有する医薬組成物
Abou-Gharbia et al. Synthesis and SAR of adatanserin: Novel adamantyl aryl-and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents
TW425398B (en) Piperazine derivatives
JP2004520382A (ja) ムスカリン受容体アゴニスト
BRPI0712730A2 (pt) Composto da fórmula i; método para o tratamento de um distúrbio do sistema nervoso central relacionado ou afetado pelo receptor 5-ht6 em um paciente que dele necessita; composição farmacêutica; processo para a preparação de um composto da fórmula ia; e uso de um composto da fórmula i
CN109195963A (zh) 作为apj激动剂的6-羟基-4-氧代-1,4-二氢嘧啶-5-甲酰胺
BRPI0710477A2 (pt) cis-4, 5- biarila - 2- imidazolinas heterocìclicas como inibidores da mdm2
JP2013532657A (ja) 環式ｎ，ｎ’−ジアリールチオ尿素及びｎ，ｎ’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用
PT100041B (pt) Processo para a preparacao de derivados de indol e de composicoes farmaceuticas que os contem
US20070191358A1 (en) Novel piperidine derivative for the treatment of depression
PT2285784E (pt) 2-metil-1-(fenilsulfonil)-4-(piperazin-1-il)-1hbenzimidazol como ligando de 5-hidroxitriptamina-6
JP4076234B2 (ja) テトラヒドロベンズインドール化合物
TW438746B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions
DE69321609T2 (de) Piperazinderivate
CN1096459C (zh) (r)－5－溴－n－(1－乙基－4－甲基六氢－1h－1,4－二氮杂䓬－6－基)－2－甲氧基－6－甲胺基－3－吡啶羧酰胺,其制备方法及含有该化合物的医药组合物
KR100768021B1 (ko) 시스-2,4,5-트리아릴-이미다졸린
DE69713110T2 (de) 4-aminoethoxy-indolon-derivate
JP3077047B2 (ja) 新規ピペラジン誘導体
JP2002513015A (ja) セロトニン作動薬としてのインドリル誘導体
TW593294B (en) Polycyclic thiazole systems having anorectic activity, processes for their preparation and pharmaceutical composition comprising these compounds
JPS6248668A (ja) キノリン誘導体とその酸付加塩、その製法及びこの化合物を含む薬用組成物
JP2883970B2 (ja) 新規１，４−（ジフェニルアルキル）ピペラジン誘導体